Progression to insulin therapy among patients with type 2 diabetes treated with sitagliptin or sulphonylurea plus metformin dual therapy-Reference-Cited by-同舟云学术

Progression to insulin therapy among patients with type 2 diabetes treated with sitagliptin or sulphonylurea plus metformin dual therapy

Published:2015-06-22 Issue:10 Volume:17 Page:956-964
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:Diabetes Obes Metab

Author:

Inzucchi S. E.¹,Tunceli K.²,Qiu Y.²,Rajpathak S.²,Brodovicz K. G.²,Engel S. S.²,Mavros P.²,Radican L.²,Brudi P.²,Li Z.³,Fan C. P. S.³,Hanna B.³,Tang J.³,Blonde L.⁴

Affiliation:

1. Section of Endocrinology Yale University School of Medicine New Haven CT USA

2. Merck & Co., Inc. Kenilworth NJ USA

3. Asclepius Analytics LLC New York NY USA

4. Ochsner Medical Center New Orleans LA USA

Funder

Eli Lilly and Company

Novo Nordisk

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/dom.12489

Reference29 articles.

1. Beta-cell dysfunction and glucose intolerance: results from the San Antonio metabolism (SAM) study

2. Insulin management of type 2 diabetes mellitus;Petznick A;Am Fam Physician,2011

3. Glycemic Control With Diet, Sulfonylurea, Metformin, or Insulin in Patients With Type 2 Diabetes MellitusProgressive Requirement for Multiple Therapies (UKPDS 49)

4. Progression to Insulin for Patients with Diabetes Mellitus Using the Texas Medicaid Database

5. Secondary Failure Rates Associated with Metformin and Sulfonylurea Therapy for Type 2 Diabetes Mellitus

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Network analysis to trace the common key gene (s) involved in antihyperglycemic effects mediated through co-supplementation of Vitamin D and Metformin;2023-12-19

2. Time in uncontrolled hyperglycemia before insulin initiation in people living with type 2 diabetes: A systematic literature review;Primary Care Diabetes;2023-12

3. Identifying the impact of health insurance on subgroups with changing rates of diagnosis;Health Economics;2023-06-12

4. Insulin Independence With SGLT2 Inhibitor Use in Type 2 Diabetes;The Journal of Clinical Endocrinology & Metabolism;2023-03-22

5. Longitudinal assessment of the quality of life and patterns of antidiabetic medication use in patients with type 2 diabetes, Saudi Arabia perspective, DISCOVER study;Current Medical Research and Opinion;2022-11-28